Sensex
83,878.17 profit arw 301.93 (0.36%)
Nifty
25,790.25 profit arw 106.95 (0.42%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 12-Jan-2026
Hot Pursuit
12-Jan-2026     15:45

SPARC gains as board to mull fund raising on 14 Jan'26

The board will evaluate a proposal to raise funds through a preferential issue, including convertible warrants, to an identified member of the promoter group, subject to receipt of all requisite approvals, consents and permissions, including from the company's shareholders as well as the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).

Sun Pharma Advanced Research Company is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery.

The company had reported a consolidated net loss of Rs 75.85 crore in the quarter ended September 2025 as against net loss of Rs 107.33 crore during the previous quarter ended September 2024. Sales declined 38.88% to Rs 7.86 crore in Q2 FY26 over Q2 FY25.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

83,878.17 301.93 (0.36%)

Nifty

25,790.25 106.95 (0.42%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,608.48 376.68(1.44%)